Histone deacetylase 2 inhibitor valproic acid attenuates bisphenol A-induced liver pathology in male mice
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Histone deacetylase 2 inhibitor valproic acid attenuates bisphenol A-induced liver pathology in male mice ; volume:12 ; number:1 ; day:17 ; month:6 ; year:2022 ; pages:1-13 ; date:12.2022
Scientific reports ; 12, Heft 1 (17.6.2022), 1-13, 12.2022
- Urheber
-
Al-Griw, Mohamed A.
Alshibani, Zaynab Osama
Alghazeer, Rabia
Elhensheri, Mohamed
Tabagh, Refaat. M.
Eskandrani, Areej A.
Alansari, Wafa S.
Habibulla, Mahmoud M.
Shamlan, Ghalia
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-12937-4
- URN
-
urn:nbn:de:101:1-2022081623242046138287
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Al-Griw, Mohamed A.
- Alshibani, Zaynab Osama
- Alghazeer, Rabia
- Elhensheri, Mohamed
- Tabagh, Refaat. M.
- Eskandrani, Areej A.
- Alansari, Wafa S.
- Habibulla, Mahmoud M.
- Shamlan, Ghalia
- SpringerLink (Online service)
Ähnliche Objekte (12)
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Histone deacetylase inhibitor attenuates experimental fungal keratitis in mice
Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease
Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice
Histone deacetylase 6 in cancer
The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo
Histone deacetylase 2 (HDAC2) attenuates lipopolysaccharide (LPS)-induced inflammation by regulating PAI-1 expression
Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines
The histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates human astrocyte neurotoxicity induced by interferon-γ
Histone deacetylase inhibitor SAHA attenuates post-seizure hippocampal microglia TLR4/MYD88 signaling and inhibits TLR4 gene expression via histone acetylation
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Histone deacetylase inhibitor attenuates experimental fungal keratitis in mice
Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease
Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice
Histone deacetylase 6 in cancer
The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo
Histone deacetylase 2 (HDAC2) attenuates lipopolysaccharide (LPS)-induced inflammation by regulating PAI-1 expression
Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines
The histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates human astrocyte neurotoxicity induced by interferon-γ
Histone deacetylase inhibitor SAHA attenuates post-seizure hippocampal microglia TLR4/MYD88 signaling and inhibits TLR4 gene expression via histone acetylation
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Histone deacetylase inhibitor attenuates experimental fungal keratitis in mice
Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease
Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice
Histone deacetylase 6 in cancer
The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo
Histone deacetylase 2 (HDAC2) attenuates lipopolysaccharide (LPS)-induced inflammation by regulating PAI-1 expression
Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines
The histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates human astrocyte neurotoxicity induced by interferon-γ
Histone deacetylase inhibitor SAHA attenuates post-seizure hippocampal microglia TLR4/MYD88 signaling and inhibits TLR4 gene expression via histone acetylation
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus